CohBar Inc (CWBR)
0.7601
-0.04
(-5.11%)
USD |
OTCM |
May 09, 16:00
CohBar Cash from Financing (TTM): 0.0349M for June 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 0.0349M |
March 31, 2023 | 0.0349M |
December 31, 2022 | -0.1395M |
September 30, 2022 | 13.81M |
June 30, 2022 | 18.23M |
March 31, 2022 | 18.57M |
December 31, 2021 | 19.69M |
September 30, 2021 | 5.742M |
June 30, 2021 | 14.96M |
March 31, 2021 | 19.16M |
December 31, 2020 | 18.26M |
September 30, 2020 | 18.54M |
June 30, 2020 | 4.861M |
March 31, 2020 | 0.4427M |
December 31, 2019 | 0.6096M |
September 30, 2019 | 0.3794M |
June 30, 2019 | 0.5224M |
March 31, 2019 | 21.69M |
Date | Value |
---|---|
December 31, 2018 | 24.32M |
September 30, 2018 | 24.47M |
June 30, 2018 | 29.28M |
March 31, 2018 | 7.961M |
December 31, 2017 | 7.438M |
September 30, 2017 | 9.473M |
June 30, 2017 | 4.779M |
March 31, 2017 | 6.016M |
December 31, 2016 | 3.703M |
September 30, 2016 | 1.475M |
June 30, 2016 | 1.211M |
March 31, 2016 | 0.0038M |
December 31, 2015 | 12.97M |
September 30, 2015 | 12.47M |
June 30, 2015 | 12.35M |
March 31, 2015 | 14.70M |
December 31, 2014 | 1.891M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.1395M
Minimum
Dec 2022
19.69M
Maximum
Dec 2021
9.042M
Average
5.742M
Median
Sep 2021
Cash from Financing (TTM) Benchmarks
Madrigal Pharmaceuticals Inc | 1.116B |
CymaBay Therapeutics Inc (DELISTED) | 345.77M |
Akero Therapeutics Inc | 353.32M |
89bio Inc | 513.11M |
Sagimet Biosciences Inc | 86.17M |